| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6126240 | Travel Medicine and Infectious Disease | 2014 | 9 Pages | 
Abstract
												Two doses of hepatitis A vaccine at a 6-month interval provided protection for most immunosuppressed RA patients. A single dose does not seem to afford sufficient protection to this group of patients.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Applied Microbiology and Biotechnology
												
											Authors
												Helena H. Askling, Lars Rombo, Ronald van Vollenhoven, Ingemar Hallén, Ã
ke Thörner, Margareta Nordin, Christian Herzog, Anu Kantele, 
											